What is AZmed?
AZmed is revolutionizing medical imaging by leveraging artificial intelligence to enhance X-ray diagnostics. The company's proprietary software assists physicians in analyzing scans more efficiently, enabling them to dedicate critical time to more complex and life-threatening examinations. As the first French company to bring AI-powered radiology software to market, AZmed is positioned to significantly impact diagnostic accuracy and workflow optimization within the healthcare sector.
How much funding has AZmed raised?
AZmed has raised a total of $17.4M across 2 funding rounds:
Angel/Seed
$1.2M
Series A
$16.2M
Angel/Seed (2019): $1.2M with participation from Angelsquare
Series A (2024): $16.2M led by Techstars, Maison Worms, and Tempact Ventures
Key Investors in AZmed
Techstars
Techstars is a global network of accelerators and venture capital funds that supports entrepreneurs and startup communities worldwide, focusing on enabling individuals to contribute to and benefit from the success of entrepreneurs.
Maison Worms
Maison Worms is an investor participating in the recent funding round for AZmed, contributing to the company's strategic growth initiatives.
Angelsquare
Angelsquare is an investment platform that connects business angels, family investment groups, and early-stage funds with promising startups, aiming to provide the necessary financial boost for their growth and success.
What's next for AZmed?
The recent major strategic investment signifies a pivotal moment for AZmed, likely enabling the company to accelerate product development, expand its market reach, and further enhance its AI algorithms. This funding round, characterized as enterprise-level, suggests a focus on scaling operations and solidifying its position in the competitive radiology market. Future growth is expected to involve deeper integration into clinical workflows and potentially exploring new diagnostic applications.
See full AZmed company page
